Comanche Biopharma
Concord, US · Founded 2020 · Delaware corporation · 4 known investors
Biotechin /comanche-biopharma
Founders & leadership
AL
Arthur LevinDirector
BB
Brendan Bulik-SullivanDirector
MM
Muzammil MansuriDirector
PA
Paul AntinoriExecutive Officer
AA
Allison AugustExecutive Officer
AT
Ann TaylorDirector
CM
Clive MeanwellDirector
AF
Allyson FelixDirector
KP
Ketan PatelDirector
MY
Michael YoungExecutive Officer
TS
Thomas Scott JohnsonExecutive Officer, Director
Investors · 4
Reported raises · per SEC filings
Form D private placements▶$37.5MraisedJan 2024 · 7 investors · PharmaceuticalsRule 506(b)
▶$37.5MraisedJan 2024 · 7 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Ann TaylorDirector
- Brendan Bulik-SullivanDirector
- Muzammil MansuriDirector
- Allison AugustExecutive Officer
- Paul AntinoriExecutive Officer
- Allyson FelixDirector
- David GrayzelDirector
- Thomas Scott JohnsonExecutive Officer, Director
- Scott GottliebDirector
- Ketan PatelDirector
- Michael YoungExecutive Officer
- Offering amount
- $75M
- Amount sold
- $37.5M
- First sale
- Dec 2023
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
▶$36.1MraisedMay 2023 · 7 investors · PharmaceuticalsRule 506(b)
▶$36.1MraisedMay 2023 · 7 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Arthur LevinDirector
- Brendan Bulik-SullivanDirector
- Muzammil MansuriDirector
- Paul AntinoriExecutive Officer
- Allison AugustExecutive Officer
- Ann TaylorDirector
- Clive MeanwellDirector
- Allyson FelixDirector
- Ketan PatelDirector
- Michael YoungExecutive Officer
- Thomas Scott JohnsonExecutive Officer, Director
- Offering amount
- $36.1M
- Amount sold
- $36.1M
- First sale
- Jun 2021
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.